Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 10;39:100558. doi: 10.1016/j.ctro.2022.12.001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s)

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Fig. 2 — (a) Kaplan-Meier curves of progression-free survival (PFS) from the initiation of pembrolizumab for patients treated with concurrent palliative radiation with pembrolizumab (n = 39), those treated with palliative radiation before the pembrolizumab (n = 32), and those without palliative radiation throughout the follow-up (n = 164). Log-rank test was examined to determine the survival difference. (b) Kaplan-Meier curves of overall survival from the initiation of pembrolizumab for patients treated with concurrent palliative radiation with pembrolizumab (n = 39), those treated with palliative radiation before the pembrolizumab (n = 32), and those without palliative radiation throughout the follow-up (n = 164). Log-rank test was examined to determine the survival difference.